Evidence map›Paper›PMID 30306667›Full record

ReviewTraffic (Copenhagen, Denmark)2019

Lysosome: The metabolic signaling hub.

Dudley W Lamming, Liron Bar-Peled

Abstract readReview
In one paragraph

Review in Traffic (Copenhagen, Denmark), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 179 citations in OpenAlex.

  1. Article
  2. Review
  3. Crinophagy in Pancreatic Beta Cells: From Insulin Granule Turnover to Diabetes Pathogenesis.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Tacrolimus inhibits CVB3-targeted regulation of TFEB by PPP3/calcineurin.Frontiers in cellular and infection microbiology · 2026
    Article
  13. Autophagy-lysosomal pathway in neurodegeneration.Molecular neurodegeneration advances · 2026
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Dudley W LammingWilliam S. Middleton Memorial Veterans Hospital, Madison, Wisconsin.ORCID 0000-0002-0079-4467
Liron Bar-PeledDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, California.ORCID 0000-0003-2687-9546
Scripps Research Institute · USUniversity of Wisconsin–Madison · US

Funding

WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI James Alexander Fitzpatrick · 2013 to 2026
$27.1M
The regulation of health and longevity by branched-chain amino acidsR01AG056771 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Dudley William Lamming · 2018 to 2026
$3.1M
The regulation of health and longevity by branched-chain amino acidsRF1AG056771 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI LAMMING, DUDLEY WILLIAM · 2023 to 2023
$2.1M
Mapping druggable co-dependency pathways in NRF2-driven lung cancersR00CA215249 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BAR-PELED, LIRON · 2019 to 2021
$727k
The regulation of health and longevity by branched-chain amino acidsR56AG056771 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI LAMMING, DUDLEY WILLIAM · 2017 to 2017
$573k
Application for Administrative Supplement to Existing Award AG050135 to Develop Research on Alzheimer's DiseaseR21AG050135 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI LAMMING, DUDLEY WILLIAM, MERRINS, MATTHEW J. · 2016 to 2017
$568k
Intervention in Progeria by Alterations in dietary macronutrient CompositionR21AG051974 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI LAMMING, DUDLEY WILLIAM · 2017 to 2018
$409k
Mapping druggable co-dependency pathways in NRF2-driven lung cancersK99CA215249 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI BAR-PELED, LIRON · 2017 to 2018
$230k
Promoting metabolic health through the reduction of dietary branched chain amino acidsI01BX004031 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · PI LAMMING, DUDLEY WILLIAM · 2018 to 2022
–
BLRD VA I01 BX004031NCI NIH HHS K99 CA215249NCI NIH HHS R00 CA215249NIA NIH HHS R01 AG056771NIA NIH HHS R21 AG050135NIA NIH HHS R21 AG051974NIA NIH HHS R56 AG056771NIA NIH HHS RF1 AG056771NIDDK NIH HHS P30 DK020579
6 · The paper itself

Abstract

For the past five decades, the lysosome has been characterized as an unglamorous cellular recycling center. This notion has undergone a radical shift in the last 10 years, with new research revealing that this organelle serves as a major hub for metabolic signaling pathways. The discovery that master growth regulators, including the protein kinase mTOR (mechanistic target of rapamycin), make their home at the lysosomal surface has generated intense interest in the lysosome's key role in nutrient sensing and cellular homeostasis. The transcriptional networks required for lysosomal maintenance and function are just being unraveled and their connection to lysosome-based signaling pathways revealed. The catabolic and anabolic pathways that converge on the lysosome connect this organelle with multiple facets of cellular function; when these pathways are deregulated they underlie multiple human diseases, and promote cellular and organismal aging. Thus, understanding how lysosome-based signaling pathways function will not only illuminate the fascinating biology of this organelle but will also be critical in unlocking its therapeutic potentials.

Indexed as

Signal TransductionAgingAnimalsHumansLysosomal Storage DiseasesLysosomesautophagylysosomemetabolic signalingmTORC1

Identifiers

PMID30306667
PMCPMC6294686
OpenAlexW2897078174

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.